Paper238274
A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
Aylward M and 3 others. Rheumatol Rehabil, 1975. Cited by 33 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis. Papers, record 238274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/238274
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Blood Proteins | Major topic |
| Gold Sodium Thiomalate | Major topic |
| Penicillamine | Major topic |
| Tryptophan | Major topic |
| Adult | |
| Aspirin | |
| Blood Sedimentation | |
| C-Reactive Protein | |
| Drug Therapy, Combination | |
| Female | |
| Haptoglobins | |
| Humans | |
| Indomethacin | |
| Male | |
| Middle Aged | |
| Phenylacetates |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20,919,366 | Fenclofenac in the treatment of rheumatoid arthritis and ankylosing spondylitis. | Proc R Soc Med | 1977 | https://conductscience.org/library/papers/20919366 | PubMed |
| 10,590,187 | Effect of short-term aspirin use on C-reactive protein. | J Thromb Thrombolysis | 2000 | https://conductscience.org/library/papers/10590187 | PubMed |
| 7,436,556 | Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine. | Ann Rheum Dis | 1980 | https://conductscience.org/library/papers/7436556 | PubMed |
| 7,039,267 | Mechanisms of action of gold. | Agents Actions | 1981 | https://conductscience.org/library/papers/7039267 | PubMed |
| 6,175,194 | A new screen for anti-inflammatory agents. Estimation of rat serum acute phase alpha2-macroglobulin levels using an electroimmunoassay. | Agents Actions | 1981 | https://conductscience.org/library/papers/6175194 | PubMed |
| 1,082,028 | The influence of treatment on the natural history of rheumatoid disease. | J R Coll Physicians Lond | 1976 | https://conductscience.org/library/papers/1082028 | PubMed |
| 1,081,416 | Inflammatory disease and its control in rheumatic disorders. | Br Med J | 1975 | https://conductscience.org/library/papers/1081416 | PubMed |
| 764,923 | Letter: Natural oestrogen replacement therapy and blood clotting. | Br Med J | 1976 | https://conductscience.org/library/papers/764923 | PubMed |
| 382,804 | The pharmacological consequences of the binding of anti-rheumatic drugs to plasma proteins in the treatment of rheumatoid arthritis. | Agents Actions | 1979 | https://conductscience.org/library/papers/382804 | PubMed |
| 61,716 | New drugs for inflammation - a clinical viewpoint for their assessment. | Agents Actions | 1976 | https://conductscience.org/library/papers/61716 | PubMed |
| 21,068 | Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders. | Drugs | 1977 | https://conductscience.org/library/papers/21068 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1,401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| FGB | 2,244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| HP | 3,240 | PubTator's text mining | https://conductscience.org/library/genes/3240 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/238274
GET https://conductscience.org/api/papers/v1/238274/authors